Scott C. Kogan

14.9k citations
138 papers · 10.6k · 4 hit papers · h-index 48

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Protein Degradation and Inhibitors
    • Retinoids in leukemia and cellular processes
    • Histone Deacetylase Inhibitors Research
    • Ubiquitin and proteasome pathways
    • Epigenetics and DNA Methylation
    • PI3K/AKT/mTOR signaling in cancer

Papers in

    • Retinoids in leukemia and cellular processes 43
    • Protein Degradation and Inhibitors 18
    • PI3K/AKT/mTOR signaling in cancer 8
    • Acute Myeloid Leukemia Research 64
    • Chronic Myeloid Leukemia Treatments 11
    • Hemophilia Treatment and Research 7

Scott C. Kogan

135 papers receiving 10.5k citations

Scott C. Kogan's Hit Papers

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia 2011 · 1.4k citations
1.4k0+13+26Years since publication4008001.2k

Peers

Scott C. Kogan
Comparison fields: 5 of 141
  • Hematology 3.8k
  • Molecular Biology 7.4k
  • Genetics 836
  • Cancer Research 943
  • Oncology 1.6k
Replace Kevin Shannon with:
Kevin Shannon United States
Jonathan D. Licht United States
Richard M. Lawn United States
Norman N. Iscove Canada
Joseph Lotem Israel
Stephen D. Nimer United States
Norio Komatsu Japan
Joop H. Jansen Netherlands
Jianxiang Wang China
Lars Rönnstrand Sweden
Scott C. Kogan relative to Kevin Shannon United States Kevin Shannon's profile →
Citations per field
00.5×1.5×
Kevin Shannon · 1×
Citations per year

Countries citing papers authored by Scott C. Kogan

Since Specialization
Citations

This map shows the geographic impact of Scott C. Kogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott C. Kogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott C. Kogan more than expected).

Fields of papers citing papers by Scott C. Kogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott C. Kogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott C. Kogan. The network helps show where Scott C. Kogan may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott C. Kogan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott C. Kogan Line = papers co-authored together Scott C. Kogan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.

#Work
1
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Hit paper breakdown →
20111447
2
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Hit paper breakdown →
2004794
3
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Hit paper breakdown →
2011775
4
An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences
Hit paper breakdown →
1987676
5 1997375
6 1989280
7 1995244
8 1999243
9 2003237
10 2011237
11 2014233
12 2008231
13 2011208
14 2009202
15 2014173
16 2013157
17 2007157
18 2008143
19 2004138
20 2010133

About Scott C. Kogan

Scott C. Kogan is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Genetics and Immunology, having authored 138 papers that have together received 10.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (64 papers), Retinoids in leukemia and cellular processes (43 papers), Acute Lymphoblastic Leukemia research (23 papers), Protein Degradation and Inhibitors (18 papers), Chronic Myeloid Leukemia Treatments (11 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Hemophilia Treatment and Research (7 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). The work is most often cited by research in Hematology (3.8k citations), Molecular Biology (7.4k citations), Genetics (836 citations), Cancer Research (943 citations) and Oncology (1.6k citations). Scott C. Kogan has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Scott W. Lowe, Jane Gitschier, Marie Doherty, Johannes Zuber, Agustin Chicas, Michelle M. Le Beau, J. Michael Bishop, Amy Rappaport, Kevin Shannon and Jerry Pelletier. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Cancer Research, Cancer Cell and Cancer Epidemiology Biomarkers & Prevention.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact